or Try an Advanced Search...

    Diabetes Care Stocks List

    Symbol Grade Name % Change
    TNDM B Tandem Diabetes Care, Inc. -4.20
    PRGO C Perrigo Company 3.18
    NVO D Novo Nordisk A/S -0.47
    View As Page of Charts
    Related Industries: Biotechnology Drug Manufacturers - Specialty & Generic Medical Devices
    Related Stock Lists: Diabetes Endocrine System Hormones Insulin Pharmaceutical Products Pharmaceuticals Segment Active Pharmaceutical Ingredients Allergy Analgesics Animal Health Anti Diabetic Drugs Biopharmaceutical Caregiver Cough Diabetes Management Diabetes Mellitus Diabetes Mellitus Type 1 Dietary Supplement Endocrinology Feminine Hygiene

    Related ETFs - A few ETFs which own one or more of the above listed Diabetes Care stocks.

    Symbol Grade Name Weight
    EDEN A iShares MSCI Denmark Capped ETF 23.21
    PPH C Market Vectors Pharmaceutical ETF 10.43
    IGTR C Innovator Gradient Tactical Rotation Strategy ETF 8.1
    PJIO D PGIM Jennison International Opportunities ETF 7.68
    AADR A WCM BNY Mellon Focused Growth ADR ETF 6.52
    View all Diabetes Care ETFs...
    Compare ETFs
    Compare EDEN to AADR Compare EDEN to IGTR Compare IGTR to PJIO

        Diabetes Care Stocks Recent News

        Date Stock Title
        May 8 TNDM Tandem insulin pump error leads to FDA Class I recall
        May 8 NVO Wall Street Bulls Look Optimistic About Novo Nordisk (NVO): Should You Buy?
        May 8 PRGO Perrigo First Quarter 2024 Earnings: EPS: US$0.03 (vs US$0.008 loss in 1Q 2023)
        May 7 PRGO Perrigo Company plc (PRGO) Q1 2024 Earnings Call Transcript
        May 7 PRGO Perrigo Company plc 2024 Q1 - Results - Earnings Call Presentation
        May 7 NVO 13 Best Stocks That Will Always Grow
        May 7 PRGO Perrigo (PRGO) Q1 Earnings Surpass, Sales Miss Estimates
        May 7 PRGO Perrigo (PRGO) Reports Q1 Earnings: What Key Metrics Have to Say
        May 7 PRGO Perrigo Co PLC (PRGO) Q1 2024 Earnings: Adjusted EPS Exceeds Expectations Despite Sales Dip
        May 7 PRGO Perrigo Non-GAAP EPS of $0.29, revenue of $1.08B
        May 7 PRGO Perrigo Reports First Quarter 2024 Financial Results From Continuing Operations
        May 7 PRGO Perrigo Announces Executive Transition for its Consumer Self-Care International (CSCI) Business
        May 6 NVO Novo Nordisk A/S purchases B shares worth DKK 5,428 million from Novo Holdings A/S under the 2024 share repurchase programme
        May 6 PRGO Watch These 5 Drug Stocks for Q1 Earnings: Beat or Miss?
        May 6 PRGO Perrigo Q1 2024 Earnings Preview
        May 6 PRGO Insights Into Perrigo (PRGO) Q1: Wall Street Projections for Key Metrics
        May 6 NVO Investors Pile Into Amgen in Search of Next Obesity Drug Payout
        May 6 NVO Novo Nordisk doses first subject in Phase I trial of NLRP3 inhibitor
        May 6 NVO 'Ozempic Ftw:' Elon Musk Touts Novo Nordisk's Blockbuster Drug As Solution To Childhood Obesity Problem
        May 5 TNDM Earnings Update: Here's Why Analysts Just Lifted Their Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Price Target To US$43.57
        Related Industries: Biotechnology Drug Manufacturers - Specialty & Generic Medical Devices
        Related Stock Lists: Diabetes Endocrine System Hormones Insulin Pharmaceutical Products Pharmaceuticals Segment Active Pharmaceutical Ingredients Allergy Analgesics Animal Health Anti Diabetic Drugs Biopharmaceutical Caregiver Cough Diabetes Management Diabetes Mellitus Diabetes Mellitus Type 1 Dietary Supplement Endocrinology Feminine Hygiene
        Diabetes Care

        Diabetes Care is a monthly peer-reviewed medical journal published since 1978 by the American Diabetes Association. The journal covers research in the following five categories: 1) clinical care/education/nutrition/psychosocial research, 2) epidemiology/health services research, 3) emerging treatments and technologies, 4) pathophysiology/complications, and 5) cardiovascular and metabolic risk. The journal also publishes clinically relevant review articles, letters to the editor, and commentaries.According to the Journal Citation Reports, the journal has a 2017 impact factor of 13.397 ranking it fifth out of 138 journals in the category "Endocrinology & Metabolism."

        More about Diabetes Care
        Browse All Tags